When Myelin's Caretakers Fail

The Glial Network in Proteostatic Crisis: Oligodendroglial Autophagy Failure and the Cascading Vulnerabilities of the Central Nervous System

Benjamin Aaron Gustafsson AdultCognitiveDisease.com

---

Abstract

The traditional neuron-centric paradigm of neurodegenerative disease has undergone a profound historiographical and theoretical paradigm shift, yielding to a more nuanced, glia-inclusive framework. Within this evolving landscape, macroautophagy—the lysosome-dependent cellular degradation system—has emerged as a paramount mechanism for maintaining metabolic and structural homeostasis in the central nervous system (CNS). This research thesis exhaustively investigates the role of oligodendrocytes in autophagy failure and explores the systemic vulnerabilities of interconnected brain cells and subcellular structures. Through a rigorous synthesis of current molecular, transcriptomic, and transgenic in vivo models, the analysis demonstrates that autophagy in myelinating glia is not merely a localized waste-clearance mechanism, but an essential driver of oligodendrocyte maturation, myelin turnover, and axon-glial metabolic coupling. The ablation of core autophagic genes, such as Atg5, specifically in oligodendrocytes precipitates the toxic accumulation of proteolipid protein (PLP), profound myelin decompaction, and progressive axonal degeneration that manifests behaviorally as motor learning deficits.

Furthermore, this thesis elucidates how oligodendroglial autophagy failure acts as a catalyst for a broader network collapse. It examines the disruption of the monocarboxylate transporter 1 (MCT1)-mediated lactate shuttle, which starves axons of metabolic substrates and provides a mechanistic basis for the "dying-back" hypothesis of neurodegeneration. Beyond the oligodendrocyte-axon unit, the investigation extends to the collateral vulnerabilities of other neuroglial and vascular populations. Astrocytes and microglia, when subjected to autophagic dysregulation, shift toward reactive, neurotoxic phenotypes characterized by impaired glymphatic clearance and hyperactive secretory autophagy—a non-lytic pathway driving the unconventional secretion of proinflammatory cytokines such as interleukin-1$\beta$ (IL-1$\beta$). Concurrently, subcellular structures like synapses suffer from local mitophagy failure and retrograde transport blockade, while the neurovascular unit experiences pericyte senescence and tight junction redistribution, compromising the blood-brain barrier (BBB). Ultimately, this thesis argues that neurodegeneration is fundamentally a network-level proteostatic crisis, driven by glial autophagy failure, necessitating a shift toward glia-targeted autophagic modulation as a premier therapeutic strategy.

Introduction

Aging represents the primary risk factor for the vast majority of neurodegenerative diseases, profoundly reshaping the cellular and molecular landscape of the central nervous system (CNS) long before overt neuronal loss or clinical symptomatology becomes apparent.¹ For decades, the dominant theoretical models of neuropathology were strictly neuron-centric, attributing diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) almost exclusively to intrinsic neuronal vulnerabilities.³ These vulnerabilities were historically defined by synaptic failure and the intracellular accumulation of misfolded proteins, including amyloid- (Aβ), -synuclein, and hyperphosphorylated tau.³ Glial cells—astrocytes, microglia, and oligodendrocytes—were historically relegated to the periphery of neurobiology, viewed merely as passive structural and trophic support systems for the neuronal parenchyma, or simply as secondary responders to primary neuronal injury.¹ However, advancing transcriptomic, proteomic, and in vivo imaging technologies have catalyzed a theoretical repositioning within the field. The traditional neuron-centric view is rapidly being replaced by a glial network-based framework, which recognizes that age-related dysfunctions in non-neuronal cells critically shape neuronal vulnerability, excitatory/inhibitory transmission imbalance, and overall circuit resilience.¹ Within this glial-centric paradigm, cellular proteostasis has been identified as a critical vulnerability. The central nervous system, characterized by extremely long-lived post-mitotic cells and immense metabolic demands, is highly susceptible to the accumulation of abnormal protein aggregates and damaged organelles, necessitating robust intracellular degradation mechanisms.⁶ Autophagy—derived from the Greek words phagos (eat) and auto (self)—is a highly conserved, lysosome-dependent catabolic mechanism responsible for the sequestration, degradation, and recycling of bulk cytoplasm, long-lived proteins, and dysfunctional organelles.⁸ While three primary modalities of autophagy exist in mammalian systems—macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA)—macroautophagy is the most extensively studied in the context of global neurodegeneration.⁹ The process involves the formation of a double-membrane structure called the phagophore, which engulfs cytoplasmic cargo to form an autophagosome, eventually fusing with a lysosome to degrade its contents via acidic hydrolases, thereby recycling macromolecular constituents back into the cytosol for bioenergetic and biosynthetic reuse.⁶ The central research problem addressed in this thesis centers on the critically understudied role of macroautophagy in oligodendrocytes (OLs) and the subsequent ripple effects of its failure across the brain's integrated networks. Oligodendrocytes are the exclusive myelinating cells of the CNS, responsible for generating and maintaining the multilamellar, lipid-rich myelin sheaths that insulate axons and facilitate the rapid, energy-efficient saltatory conduction of action potentials.¹¹ The metabolic demand placed on these cells is extraordinary; a single mature oligodendrocyte must synthesize massive quantities of lipids and structural proteins to enwrap up to fifty distinct axonal internodes, placing immense strain on their endoplasmic reticulum (ER) and baseline proteostatic machinery.¹³ Consequently, oligodendrocytes are profoundly vulnerable to protein misfolding, lipid peroxidation, and autophagic failure.¹³ This thesis hypothesizes that the failure of macroautophagy in oligodendrocytes operates as a primary pathogenic event that not only compromises myelin integrity and induces autonomous glial apoptosis but also directly triggers distal axonal degeneration through the severing of critical metabolic coupling mechanisms. Furthermore, it is argued that the resulting accumulation of myelin debris and metabolic dysregulation precipitates secondary autophagic failures in surrounding microglia, astrocytes, and the neurovascular unit, culminating in chronic neuroinflammation and profound structural brain damage. By systematically analyzing the specific vulnerabilities of these interconnected cell types and subcellular compartments, this research seeks to establish a comprehensive, integrated model of glia-driven neurodegeneration, moving beyond the isolated neuron to understand the brain as a mutually dependent proteostatic ecosystem.

Literature Review: Historiographical and Theoretical

Positioning

The Evolution of the Glial-Network Paradigm

The historiography of neurodegeneration research reveals a distinct and measurable trajectory from the foundational, neuron-centric postulates of the 20th century to the highly integrated, neuroglial network models that dominate contemporary neuroscience. Early conceptualizations of diseases like Alzheimer's and Parkinson's isolated the neuron as the sole locus of disease initiation.³ Histopathological diagnoses relied almost exclusively on identifying intraneuronal Lewy bodies, neurofibrillary tangles, and extracellular amyloid plaques, leading to the formulation of the amyloid cascade hypothesis and similar neuron-centric models.³ Within this historical framework, glia were largely excluded from mechanistic models of disease progression. They were perceived as ancillary entities that merely reacted to, rather than initiated, neural injury, functioning essentially as the brain's connective tissue and rudimentary immune responders.¹ This theoretical positioning began to shift drastically with the identification of "inflammaging"—a state of chronic, low-grade, sterile inflammation that accompanies physiological aging and serves as a fundamental driver of neurodegenerative pathology.¹ Accumulating evidence over the past two decades has highlighted microglia, astrocytes, and oligodendrocytes as central drivers of neuroinflammation, actively participating in synapse elimination, metabolic regulation, and the propagation of disease states.³ For instance, it is now understood that activated microglia rapidly sense pathological signals through pattern-recognition receptors (e.g., TLR4) and shift from a homeostatic surveillance state to a disease-associated pro-inflammatory state.³ This shift is marked by the increased release of cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-1β (IL-1β), and interleukin-6 (IL-6), which subsequently drive reactive astrocytosis and further neuronal toxicity.³ This paradigm shift has necessitated a fundamental reevaluation of core cellular processes, such as autophagy, requiring researchers to analyze these mechanisms through a comprehensive glia-inclusive lens.¹

The Expanding Taxonomy of Autophagic Modalities

Theoretical frameworks regarding autophagy itself have also undergone significant revision and expansion. Originally conceptualized in the mid-20th century merely as a bulk, non-selective degradation pathway activated under conditions of severe nutrient starvation, autophagy is now understood to encompass highly selective organellophagy, which is absolutely crucial for baseline cellular quality control even in nutrient-rich environments.⁶ The contemporary literature identifies three distinct autophagic subtypes:

1. Macroautophagy: The canonical pathway involving the de novo formation of double-membrane autophagosomes that sequester cytosolic materials and deliver them to lysosomes.⁷
2. Microautophagy: The direct invagination of the lysosomal membrane to engulf small portions of the cytosol or specific organelles without the intermediate formation of an autophagosome.¹⁰
3. Chaperone-Mediated Autophagy (CMA): A highly selective, non-vesicular process wherein specific substrate proteins containing a biochemically distinct KFERQ-like pentapeptide motif are directly recognized by the heat-shock cognate protein 70 (Hsc70) chaperone complex.¹⁴ These substrates are then unfolded and directly translocated across the lysosomal membrane via the lysosome-associated membrane protein type 2A (LAMP-2A) receptor.¹⁴ Additionally, macroautophagy is increasingly categorized by its highly selective cargo recognition mechanisms, mediated by specific adaptor proteins (such as p62/SQSTM1). This selective taxonomy includes mitophagy (targeting damaged mitochondria), pexophagy (targeting peroxisomes), reticulophagy or ER-phagy (targeting portions of the endoplasmic reticulum), and aggrephagy (targeting ubiquitinated protein aggregates).¹⁷ In the context of the CNS, the dynamic crosstalk between CMA and macroautophagy is of particular historiographical and theoretical interest. The literature posits that they act as interconnected, compensatory systems; the blockage of CMA can induce the compensatory upregulation of macroautophagy to maintain neuronal homeostasis.¹⁸ However, the reverse is functionally limited: while macroautophagy can degrade bulk CMA substrates when CMA fails, it cannot completely compensate for the highly selective, finely tuned degradation of particular signaling molecules normally managed by CMA, leading to specific cellular vulnerabilities.¹⁵

Theoretical Reframing of White Matter Disease

Historically, demyelinating diseases such as multiple sclerosis (MS) and rare genetic leukodystrophies like Pelizaeus-Merzbacher disease (PMD) and Alexander disease (AxD) were viewed through highly restricted pathological lenses. MS was viewed primarily as an exogenous disorder of autoimmune infiltration, while leukodystrophies were seen as simple genetic synthesis errors resulting in the catastrophic failure of myelin formation.¹⁹ Recent literature, however, reframes these white matter disorders as fundamental, intrinsic failures of glial proteostasis and autophagic flux.⁸ For example, mutations in the PLP1 gene in PMD lead to the massive accumulation of misfolded proteins in oligodendrocytes. This accumulation triggers the Unfolded Protein Response (UPR)-induced apoptotic pathway, leading to the structural splitting and decompaction of myelin sheaths and the formation of axonal spheroids.²¹ Similarly, mutations in the GFAP gene in AxD cause toxic accumulations of intermediate filaments known as Rosenthal fibers in astrocytes, overpowering their autophagic capacity.¹⁹ This thesis intervenes directly in current academic debates by synthesizing these distinct pathologies into a unified, coherent model of glial autophagy failure, arguing that the inability of glia to process their own metabolic and structural waste acts as the primary, cell-autonomous catalyst for subsequent immune activation and non-autonomous neuronal loss.⁸

Methodology: Explicit Methods, Sources, and Disciplinary Approach

Investigating the cell-type-specific role of autophagy within the intact, living brain poses significant methodological and analytical challenges. Autophagy is a highly dynamic, multi-step process characterized not by static levels of pathway proteins, but by the continuous rate of degradation, formally termed "autophagic flux".²⁴ Simply measuring the steady-state abundance of autophagosomes via Transmission Electron Microscopy (TEM) cannot distinguish between a robustly active autophagic pathway producing many vesicles and a pathologically blocked pathway where vesicles are accumulating due to fusion failure.²⁵ To definitively answer how oligodendroglial autophagy failure impacts the broader CNS, contemporary cognitive neuroscience and molecular biology rely on a rigorous combination of advanced transgenic models, targeted pharmacological flux measurements, and multi-omics profiling.

Methodological Approach Primary Application in Inherent Limitations &

Autophagy Research Caveats

Genetic Ablation Conditional knockout of Recombination efficiency

(Cre/LoxP) Atg5 or Atg7 to isolate varies; compensatory

cell-autonomous effects in upregulation of alternative glia without inducing degradation pathways (e.g., systemic embryonic CMA) may mask early lethality.²⁶ phenotypes.¹⁸

Pharmacological Use of Chloroquine (CQ) or Potential off-target cellular

Blockade Bafilomycin A1 (BafA1) to toxicity; difficulty achieving

inhibit lysosomal uniform delivery across the fusion/acidification, blood-brain barrier in living allowing measurement of animals.²⁴ true autophagic flux in vivo.²⁴

Tandem Fluorescent Expression of High cytosolic background

Reporters mCherry-GFP-LC3 from unconjugated

constructs to dynamically fluorophores; differentiate between overexpression artifacts neutral autophagosomes may not reflect (yellow) and acidic physiological endogenous autolysosomes (red).²⁸ promoter activity.³⁰

Multi-Omics Profiling LC-MS-MS and RNA-seq to Provides correlative rather

quantify downstream than direct causal evidence; transcriptomic and temporal delays between proteomic alterations mRNA transcription and following autophagic protein execution.³³ blockade.³³

Genetic Ablation Models in the CNS

To circumvent the rapid embryonic or early postnatal lethality associated with global knockouts of core autophagy genes like Atg5 and Atg7, researchers utilize the site-specific Cre/loxP recombination system to generate conditional knockouts (cKOs) restricted to varied neural lineages.²⁶ In the specific context of analyzing myelinating glia, the plp-CreERT2; atg5f/f mouse model represents the methodological gold standard. By crossbreeding mice carrying floxed Atg5 alleles with tamoxifen-inducible plp-CreERT2 transgenic mice, researchers can selectively ablate the Atg5 gene exclusively in mature, proteolipid protein (PLP)-expressing oligodendrocytes at specific adult time points (e.g., initiating tamoxifen injections at 2.5 months of age and analyzing the pathology at 6 months).¹¹ The efficiency and spatial restriction of this recombination are rigorously verified using a dual-fluorescent mT/mG reporter line. In this system, tamoxifen administration causes a genetic shift where red fluorescence (tdTomato) is permanently replaced by cell membrane-localized enhanced green fluorescent protein (EGFP) strictly in the myelin tracts of the optic nerve, corpus callosum, and sagittal brain sections, remaining notably absent in control littermates.³⁵ This precise spatial and temporal control is crucial for epistemological validity, preventing the confounding, system-wide effects of autophagic inhibition in astrocytes, microglia, or neurons, thereby allowing for a highly precise analysis of cell-autonomous versus non-autonomous phenotypes.²⁶

Pharmacological Blockade and Flux Quantification

Measuring true autophagic flux in vivo requires observing the rate of accumulation of autophagosomes strictly following the inhibition of lysosomal fusion or degradation. Pharmacological agents such as Chloroquine (CQ) and Bafilomycin A1 (BafA1) are utilized to block the autophagosome-lysosome fusion step or inhibit lysosome-mediated enzymatic proteolysis via the neutralization of the highly acidic lysosomal pH.²⁴ The rate of autophagosome accumulation over time represents the true autophagic flux, fundamentally distinguishing functional degradation from pathological stalling.²⁵

Tandem Fluorescent Reporters

To visualize flux dynamically, researchers employ tandem fluorescent-tagged LC3 constructs, such as the monomeric mCherry-GFP-LC3 or mTagRFP-mWasabi-LC3, typically delivered via adeno-associated viruses (AAV) into the brain or expressed via transgenic mouse lines like the CAG-RFP-EGFP-LC3 reporter.²⁹ This technique exploits the differential pH sensitivity of the two linked fluorophores. When the LC3 protein is bound to the newly formed autophagosome (which maintains a mildly acidic or neutral internal pH), both the GFP and mCherry proteins fluoresce, yielding a combined yellow signal under microscopy.²⁸ However, upon fusion with the highly acidic lysosome to form an autolysosome, the pH-sensitive GFP signal is rapidly quenched and destroyed, leaving only the stable, pH-resistant red mCherry signal visible.²⁸ Thus, a high yellow-to-red ratio indicates impaired flux (the pathological accumulation of unfused autophagosomes), while a dominant red signal indicates healthy, ongoing autolysosomal clearance.²⁸ While powerful, this methodology requires rigorous disciplinary scrutiny due to inherent caveats. The unconjugated (unlipidated) LC3 fusion proteins can exist freely in the cytosol, creating a high level of background fluorescence that is difficult to filter when baseline autophagic flux is low.³¹ Furthermore, the overexpression of LC3 fusion proteins is often driven by constitutive viral promoters rather than physiological endogenous promoters, meaning the abundance of the reporter protein can change rapidly in response to post-translational regulation, potentially skewing the interpretation of autophagic induction versus mere protein accumulation.³²

Multi-Omics and Mass Spectrometry

To elucidate the complex, downstream molecular consequences of disrupted autophagic flux in oligodendrocytes, researchers employ high-throughput quantitative liquid chromatography with tandem mass spectrometry (LC-MS-MS) and bulk RNA sequencing (RNA-seq).³³ These systems-biology approaches allow for the broad, unbiased quantification of transcriptomic and proteomic changes, revealing exactly how autophagy genetically interacts with cellular survival pathways. For instance, transcriptomic analyses have successfully demonstrated that disrupting autophagy flux in oligodendrocyte precursor cells significantly decreases the expression of pro-apoptotic genes belonging to the Bcl-2 family, such as Pmaip1 (Noxa) and PUMA (Bbc3), fundamentally altering pre-oligodendrocyte cell fate, maturation trajectories, and survival probabilities.³³

Chapter 1: The Locus of Proteostatic Failure

Oligodendrocytes and Myelin Maintenance

Oligodendrocytes serve as the premier architectural engineers of the CNS white matter. The generation, compaction, and lifelong maintenance of myelin requires an astonishingly high rate of lipid and protein synthesis.¹¹ Consequently, they are profoundly reliant on highly efficient, high-capacity protein quality control mechanisms to prevent cellular toxicity.

Myelin Homeostasis and PLP Accumulation

Myelin is not a static, inert structure; rather, it undergoes constant, dynamic remodeling and turnover—involving continuous replenishment and degradation—to maintain functional plasticity, ensure efficient nerve conduction, and prevent age-related decline.³⁵ While peripheral microglia and astrocytes participate heavily in clearing extracellular myelin debris via phagocytosis following injury, autophagy serves as the indispensable, internal degradative pathway within the oligodendrocytes themselves to process excess or senescent myelin proteins under healthy, steady-state conditions.⁸ The two core structural proteins comprising the bulk of CNS myelin are proteolipid protein (PLP), constituting approximately 50% of the total myelin protein mass, and myelin basic protein (MBP).¹¹ In vitro tracking studies evaluating oligodendrocyte maturation delineate five distinct morphological stages (Stages 0-4), where Stage 4 represents the final maturation phase characterized by a fully developed myelin membrane sheet surrounding all cellular branches.³⁵ Experimental evidence dictates that autophagic inhibition fundamentally prevents oligodendrocytes from reaching this terminal maturation stage.³⁵ Crucially, research utilizing the plp-CreERT2; atg5f/f conditional knockout model has definitively proven that both PLP and MBP are incorporated directly into autophagosomes for degradation during normal turnover.¹¹ When the core autophagic machinery is ablated in vivo, oligodendrocytes suffer an immediate and severe homeostatic crisis. Because PLP is highly abundant and heavily reliant on somatic autophagic clearance, its failure to be degraded results in a massive intracellular accumulation. Biomarker / Phenotype Wild-Type (Control) Atg5 cKO (plp-CreERT2;

Outcomes atg5f/f) Outcomes

Proteolipid Protein (PLP) Baseline expression >2.5-fold increase, with

(normalized to 1.0) accumulation of dimeric forms.³⁵

Myelin Basic Protein Baseline expression Stable expression; no

(MBP) (normalized to 1.0) significant pathological

accumulation.³⁵ Myelin Structure (EM Compact, stable Severe decompaction, Analysis) multilamellar sheaths abnormally thick sheaths, structural splitting.¹¹ Rotarod Motor Learning Significant latency Failure to improve latency;

(Day 1 to 3) improvement (skill severe motor learning

acquisition) deficits.³⁵ Notably, MBP does not accumulate to the same toxic extent in vivo following Atg5 ablation.³⁵ This divergence is biologically profound: it is highly likely that because MBP mRNA is transported away from the soma and translated locally at the distal myelin membrane sheath, it is subjected to different, localized regulatory degradation pathways less immediately dependent on somatic macroautophagy.³⁵

Morphological Defects and Behavioral Phenotypes

The accumulation of PLP due to autophagic depletion causes significant structural degradation of the myelin sheath. Electron microscopy (EM) analysis of the optic nerve and corpus callosum reveals severe morphological defects, primarily characterized by the widespread decompaction of the myelin membrane and the formation of abnormally thick, functionally unstable sheaths.¹¹ Crucially, while the loss of autophagy does not immediately trigger widespread oligodendrocyte cell death (as evidenced by the absence of cleaved caspase-3 activity for up to 3 months post-ablation), the compromised myelin integrity leads inevitably to rapid secondary axonal degeneration.³⁵ Behaviorally, these molecular and structural defects manifest as pronounced motor learning deficits. In accelerating rotarod tasks, aged mice with oligodendrocyte-specific autophagy depletion fail to exhibit standard motor skill acquisition over consecutive training days, alongside exhibiting mild dysfunction in basic motor coordination.²⁷ This specific phenotype bears striking molecular and behavioral resemblance to Pelizaeus-Merzbacher disease (PMD), a severe, incurable leukodystrophy caused by PLP1 gene duplication or mutation, which results in toxic PLP accumulation, segmental demyelination, secondary axonal degeneration, and eventual mortality.²¹

Selective ER-Phagy and Pexophagy in Oligodendrocytes

Beyond bulk macroautophagy, oligodendrocytes rely heavily on highly selective autophagic pathways to survive their own metabolic output. To manage the massive influx of nascent proteins during developmental myelination and adult myelin maintenance, cells utilize specialized ER-protein quality control (ERQC) systems, including Endoplasmic Reticulum-Associated Degradation (ERAD) via the proteasome.¹³ When unstructured or misfolded glycoproteins overwhelm the folding capacity of the ER, an adaptive signal transduction pathway known as the Unfolded Protein Response (UPR) is triggered via three parallel branches: IRE1, PERK, and ATF6α.¹³ Impaired UPR in mature oligodendrocytes directly causes intracellular PLP accumulation, catastrophic autophagic impairment, and late-onset cell death, mimicking the exact pathology of core macroautophagy failure and highlighting the absolute necessity of selective ER-phagy in mitigating dysmyelination and proteotoxicity.⁴⁴ Simultaneously, myelin sheaths are incredibly rich in specialized lipid species requiring extensive peroxisomal metabolism.⁴⁵ Pexophagy—the selective autophagic degradation of damaged or excess peroxisomes—is therefore crucial for maintaining peroxisomal homeostasis in the white matter.¹⁷ In X-linked adrenoleukodystrophy (X-ALD), a devastating white matter disorder caused by ABCD1 gene mutations, very long-chain fatty acids (VLCFAs) fail to be properly metabolized and consequently accumulate in the CNS.²¹ This toxic VLCFA accumulation induces severe oxidative stress and profoundly alters autophagic pathways.²¹ Analyses of human X-ALD brain samples and Abcd1 knockout mouse models reveal significantly impaired autophagic flux within the CNS, marked by decreased LC3-II levels and pathologically increased p62 levels, which ultimately drives relentless axonal degeneration and neurological decline.²¹

Chapter 2: Severing the Lifeline: Autophagy and Oligodendrocyte-Axon Metabolic Coupling

While the structural integrity of myelin is critical for the physical insulation and rapid propagation of action potentials, oligodendrocytes perform an equally vital, yet historically underappreciated, non-canonical function: providing relentless metabolic and trophic support to the axons they enwrap.¹² Axons, physically distanced by vast magnitudes from their own neuronal soma, possess insufficient intrinsic capacity to maintain their own extremely high energy demands.⁴⁸ They are particularly vulnerable during rapid repetitive firing, which requires massive ATP generation for ion pump operation and precise calcium buffering.⁴⁹

The MCT1-Mediated Lactate Shuttle

The prevailing, empirically supported mechanism of this continuous trophic support is the oligodendrocyte-neuron lactate shuttle.⁵⁰ Oligodendrocytes take up blood glucose via specific transporters, undergo rapid glycolysis, and produce high volumes of metabolic substrates such as lactate and pyruvate.¹² These vital energy substrates are exported out of the oligodendrocyte myelin compartment directly into the periaxonal space via the monocarboxylate transporter 1 (MCT1), and are subsequently imported into the axonal compartment via the highly affine neuronal transporter, MCT2.⁵⁰ The expression, density, and stability of MCT1 at the plasma membrane are fundamentally regulated by autophagic and endo-lysosomal pathways. Research indicates that the canonical Wnt/ -catenin signaling pathway up-regulates MCT1 protein expression specifically by inhibiting its ubiquitination and preventing its subsequent degradation within the endosomal/lysosomal system.⁵⁴ Consequently, generalized disruptions in oligodendroglial autophagy can drastically alter the surface availability of MCT1, choking off the energy supply to the axon. Furthermore, the transcription factor EB (TFEB) and the mechanistic target of rapamycin complex 1 (mTORC1) play complex, antagonistic roles in this metabolic coupling. While mTORC1 activation is required to regulate oligodendrocyte myelination and stimulate the massive lipid synthesis required for myelin assembly, prolonged or unregulated activation of mTORC1 at the lysosomal surface acts as an absolute brake on autophagy.⁵⁵ mTORC1 actively inhibits the initiation complex (ULK1/ATG13/FIP200) and directly phosphorylates TFEB, trapping this master autophagic transcription factor in the cytoplasm and preventing the transcription of vital pro-autophagic and lysosomal biogenesis genes.⁵⁶ Therefore, a highly calibrated balance of autophagic flux is required to maintain MCT1 availability without degrading it prematurely.

Autophagy Failure and the "Dying-Back" Hypothesis

When the lactate shuttle fails—whether through targeted conditional ablation of MCT1 specifically in the oligodendrocyte lineage or secondary to generalized oligodendroglial autophagy failure—the consequences for the dependent neuron are universally catastrophic.⁵⁰ Longitudinal in vivo studies demonstrate that MCT1 ablation causes progressive, age-dependent hypomyelination and significant axonal degeneration.⁴⁸ Crucially, this metabolic disruption provides a highly compelling mechanistic and theoretical explanation for the "dying-back" hypothesis of neurodegeneration. In many severe neurodegenerative conditions, including ALS and multiple system atrophy (MSA), the neuronal pathology does not initiate at the soma; rather, the axon progressively degenerates from its most distal terminal, dying backward toward the cell body.⁶⁰ Distal neurites and synaptic terminals are highly fragile due to their extreme physical distance from the somatic protective machinery and their profound reliance on the local metabolic support provided by adjoining glial cells.⁶² When oligodendrocyte autophagy fails, the subsequent accumulation of toxic myelin debris (such as PLP aggregates) and the failure of vesicular trafficking impair the ability of the oligodendrocyte to maintain MCT1 surface expression, effectively stopping the supply of lactate.⁴⁴ Starved of these critical energetic substrates, the distal axon is unable to maintain membrane polarization or axonal transport. It undergoes rapid, granular disintegration of its cytoskeleton, followed by the appearance of myelin ovoids and eventual necroptosis, progressing retrogradely.³⁴ Thus, the classical neurodegenerative phenotype—widely attributed for decades to intrinsic, cell-autonomous neuronal failure—may, in fact, be the terminal result of localized glial starvation driven by autophagic collapse.

Chapter 3: The Contagion of Failure: Astrocytes and Microglial Secretory Autophagy

The failure of proteostasis in oligodendrocytes and the resulting release of myelin debris and metabolic stress signals do not occur in an isolated vacuum. Because the brain operates as a highly integrated syncytium, these local failures trigger profound, often maladaptive shifts in the broader neuroglial network. Astrocytes and microglia, representing the innate immune and primary homeostatic regulators of the CNS, are highly sensitive to these perturbations, and their own autophagic pathways are deeply implicated in the progression and exacerbation of neurodegenerative disease.⁹

Astrocyte Autophagy and the Neurovascular Interface

Astrocytes are the most abundant glial cells in the mammalian brain, featuring incredibly complex, highly arborized morphologies that extend specialized endfeet to enwrap approximately 99% of the cerebral microvasculature, forming a critical, physical component of the blood-brain barrier (BBB).⁶⁵ Astrocytic autophagy is vital for regulating the expression and recycling of crucial plasma membrane transporters—such as the glucose transporter (GLUT1) and excitatory amino acid transporters (EAATs)—that manage nutrient uptake and prevent glutamate excitotoxicity at the synapse.⁶⁵ In neurodegenerative states like AD and PD, the mTOR signaling pathway in astrocytes becomes pathologically upregulated, acting as a master suppressor of autophagy initiation.⁶⁵ Concurrently, the accumulation of pathogenic proteins (like misfolded tau) causes the degradation of the astrocytic microtubule network and the depolymerization of vimentin intermediate filaments.⁶⁵ Because the transport of autophagosomes and their subsequent fusion with lysosomes are strictly dependent on an intact, functioning cytoskeleton, this disruption leads to a massive accumulation of immature, non-functional autophagic vacuoles juxtaposed abnormally near the nucleus.⁶⁵ This autophagic arrest triggers a severe phenotypic shift known as reactive astrogliosis.⁶⁵ Without functional autophagy to clear intracellular waste, astrocytes default to an inflammatory state, activating the NLRP3 inflammasome.⁶⁵ The inflammasome utilizes caspase-1 to cleave pro-IL-18 and pro-IL-1β into their active, highly inflammatory forms.⁶⁵ The release of these potent cytokines directly into the perivascular space degrades the neurovascular interface, contributing heavily to chronic neuroinflammation.³ Furthermore, the loss of cytoskeletal integrity compromises the precise polarization and localization of the aquaporin-4 (AQP4) water channels at the astrocyte endfeet, severely impairing the brain's glymphatic clearance system and trapping toxic metabolic waste within the deep parenchyma.⁶⁵

Microglial Autophagy and the Transition to Neurotoxicity

Microglia are the resident macrophages of the CNS, constantly extending and retracting their processes to survey the parenchyma for invading pathogens, misfolded proteins, and cellular debris.⁹ Under normal physiological conditions, microglial macroautophagy acts synergistically with phagocytosis to facilitate the engulfment and lysosomal degradation of apoptotic cells, amyloidplaques, and stripped synaptic material.⁹ This degradative process negatively regulates neuroinflammation, preserving a quiescent, homeostatic environment.⁶⁸ The induction of microglial autophagy is mediated by specific surface receptors, including Toll-like receptor 4 (TLR4), TREM2, and P2X7R, which interface directly with internal autophagic signaling cascades like the PI3K-Akt, FOXO3, and AMPK-mTOR pathways.⁶⁹ However, when overwhelmed by the immense burden of massive Aβ accumulation, p-Tau tangles, or the overwhelming volume of myelin debris resulting from primary oligodendrocyte failure, microglial autophagy mechanisms become severely dysregulated.⁶⁹ Excessive, chronic activation of TLR4, for example, heavily inhibits the PI3K-Akt pathway, reducing overall autophagic flux and suppressing the transcription of essential Atg genes.⁶⁹ This catastrophic failure of degradative macroautophagy forces microglia to abandon their protective surveillance role.

The Paradox of Secretory Autophagy

Perhaps the most pernicious and destructive consequence of this network failure is the hyperactivation of secretory autophagy (SA). Distinct from canonical degradative macroautophagy—which safely fuses autophagosomes with highly acidic lysosomes to destroy their contents—secretory autophagy is an unconventional, non-lytic pathway.⁷⁰ When the degradative pathway is blocked, the cell redirects the autophagosome to fuse directly with the plasma membrane, expelling its undegraded, often toxic cargo outward into the extracellular space.⁷⁰

Autophagic Primary Function Molecular Drivers Pathological

Pathway in Glia & Scaffolding Outcome When

Proteins Dysregulated

Canonical Clearance of Atg5, ULK1, VPS34, Failure leads to Degradative Aβ, myelin Lysosomal intracellular toxic

Macroautophagy debris, and Hydrolases. accumulation and

suppression of initiates the shift to inflammation. secretory pathways.

Unconventional Export of cellular SKA2, FKBP5, Hyperactivation

Secretory contents to the RQ-SNARE complex releases toxic levels

Autophagy (SA) extracellular space (SNAP29, SEC22B). of IL-1β and

(non-lytic). Cathepsin D, driving severe neurodegeneration. This unconventional secretion pathway is highly regulated and driven by specialized scaffolding proteins, notably FKBP5 (FK506-binding protein 51) and SKA2 (Spindle and Kinetochore-associated complex subunit 2).⁷⁰ These stress-inducible scaffolding proteins interact specifically with the RQ-SNARE fusion complex, which includes SNAP29 (synaptosomal-associated protein 29) and SEC22B (vesicle-trafficking protein), to facilitate the tethering and fusion of the secretory autophagosome with the plasma membrane.⁷⁰ When the normal degradative autophagic capacity of microglia is blocked by disease pathology, SA becomes hyperactive.⁷⁰ This results in the massive, unconventional secretion of pro-inflammatory cytokines such as IL-1β and lysosomal enzymes like Cathepsin D directly into the brain parenchyma.⁷⁰ This continuous, unregulated secretion establishes a devastating, self-reinforcing neuroinflammatory loop: failing oligodendrocytes trigger microglial activation; failing to degrade the debris, microglia shift to secretory autophagy, releasing toxic cytokine storms that induce further astrogliosis, BBB breakdown, and widespread neuronal death.³

Chapter 4: Terminal Vulnerabilities: Subcellular

Structures and the Neurovascular Unit

As the proteostatic crisis cascades violently from the oligodendrocyte through the broader glial network, specific subcellular structures and vital vascular components exhibit profound, terminal vulnerabilities.

Synaptic Vulnerability and Retrograde Transport Failure

Synapses represent the primary site of early physiological dysfunction in multiple neurodegenerative diseases, often correlating strongly with the onset of cognitive decline before any gross neuronal death is observed.⁴ Their unique physical architecture and physiological demands render them exceptionally vulnerable to general autophagy failure. Synapses must maintain an enormous density of localized proteins required for continuous neurotransmitter release and receptor cycling, including presynaptic machinery like synaptobrevin and synaptotagmin, as well as postsynaptic NMDA and AMPA receptor subunits.⁴⁹ Because synapses are located at immense physical distances from the somatic cell body, local housekeeping is absolutely essential to prevent protein aggregation and organelle failure.⁴⁹ They rely heavily on highly localized mitophagy to manage immense energy (ATP) demands and buffer the massive calcium transients required for synaptic transmission; the critical nature of this local control is underscored by the fact that mRNA for Pink1, a key mitophagy adaptor protein, is cotransported directly down the axon to the synapse for immediate local synthesis.⁴⁹ Canonical neuronal macroautophagy initiates with the de novo formation of autophagosomes at the extreme distal axon terminal, followed by necessary retrograde transport via dynein motor proteins back up the axon to the soma, where lysosomes are concentrated for fusion and degradation.⁷ In disease states such as AD, pathogenic proteins like Aβ oligomers interact directly with the traveling autophagic vacuoles and the dynein machinery itself.⁴⁹ This physical interference halts retrograde transport, leading to a massive, toxic buildup of autophagic vacuoles within dystrophic neurites.⁴⁹ This transport arrest creates a catastrophic, localized feedback loop: the accumulated vacuoles provide an optimal biochemical environment that actually facilitates the increased cleavage of amyloid precursor protein (APP) into toxic Aβ right at the synapse, accelerating synaptic collapse.⁴⁹

Lysosomal Acidification Failure

Even if autophagosomes successfully navigate the long axonal tracts, they frequently encounter terminal failure at the soma due to intrinsic lysosomal dysfunction. Efficient proteolysis within the autolysosome requires an intensely acidic environment (typically a pH of ~4.5 to 5.0). In early-onset familial Alzheimer's disease (FAD), highly penetrant mutations in the PSEN1 (Presenilin-1) gene, which encodes the primary catalytic subunit of the -secretase complex, have been shown to drastically disrupt this fundamental process.⁷³ Loss of normal PS1 function impairs the vital glycosylation, maturation, and targeting of the V0a1 subunit of the vacuolar (H+)-ATPase complex to the lysosomal membrane.⁷³ This targeting failure prevents proper lysosomal acidification (resulting in pathological alkalinization), which effectively neutralizes the resident cathepsin proteases, rendering the entire autolysosomal compartment incompetent.⁷³ Consequently, partially digested, highly toxic products accumulate endlessly, eventually leading to severe lysosomal membrane destabilization. The subsequent leakage of the remaining, active proteases into the cellular cytosol serves as a potent trigger for initiating necrotic or apoptotic cell death cascades.⁷³

Collapse of the Neurovascular Unit

The ultimate, systemic victim of this widespread glial autophagy failure is the neurovascular unit (NVU), the intricate functional complex composed of specialized endothelial cells, contractile pericytes, and astrocytic endfeet that rigorously regulates cerebral blood flow and maintains the selective permeability of the BBB.⁶⁵ Brain microvascular endothelial cells, which form the primary, restrictive tight junctions of the BBB, are highly sensitive to the metabolic starvation and inflammatory cytokines resulting from glial failure. Studies rigorously indicate that under conditions of prolonged starvation or oxygen-glucose deprivation (OGD)—replicating the severe ischemic conditions seen in stroke or advanced neurovascular uncoupling—autophagy is aberrantly, pathologically activated via the acute inhibition of the Akt-mTOR-p70S6K signaling pathway.⁷⁸ This unconstrained, stress-induced autophagy directly targets and degrades crucial tight junction proteins, specifically occludin and Claudin-5 (Cldn5).⁷⁸ The autophagic degradation causes the rapid redistribution of Cldn5 from the functional endothelial cell membrane into the cytosol, leading to the rapid physical breakdown of the barrier and allowing neurotoxic blood-derived proteins to flood the brain parenchyma.⁷⁸ Simultaneously, brain pericytes, which wrap intimately around capillary walls to regulate vasomotor function and neurovascular coupling, are highly vulnerable to autophagic disruption.⁸⁰ Defective autophagy in pericytes directly drives cellular senescence.⁸⁰ The degeneration, loss, and senescence of capillary pericytes completely decouple capillary blood flow responses from local neuronal stimulus, leading to severe neurovascular uncoupling.⁸³ This uncoupling means the brain can no longer increase blood flow to areas of high neural activity. This exacerbates the hypoxic and metabolic stress on the already starving neurons and failing oligodendrocytes, cementing a vicious, inescapable, and terminal cycle of neurodegeneration.⁸³

The Validity Ledger

The argument above is only as strong as its weakest load-bearing joint, and the reader is owed an explicit accounting of where it stands on the ground and where it stands on inference.

Conclusion

The extensive findings synthesized within this thesis conclusively demonstrate that neurodegenerative disease can no longer be accurately or effectively modeled as a strictly neuron-autonomous process of isolated protein aggregation and localized synaptic failure. Instead, it must be understood as a profound, systemic proteostatic crisis driven by cascading autophagic failure across the entire, integrated neuroglial network. Oligodendrocytes, burdened by the extraordinary metabolic and structural demands of myelin synthesis and lifelong maintenance, represent a critical, highly vulnerable initial node in this network. The specific failure of canonical macroautophagy and targeted ER-phagy within myelinating glia not only causes the toxic, intracellular accumulation of structural proteins like PLP, but it also physically and metabolically isolates the axon by dismantling the essential MCT1-mediated lactate shuttle. This localized oligodendrocyte starvation triggers the distal-to-proximal "dying-back" of dependent neurons and releases damage-associated molecular patterns that plunge the surrounding glial network into a state of severe, reactive toxicity. Astrocytes, plagued by cytoskeletal degradation and pathological mTOR upregulation, fail to maintain the blood-brain barrier and vital glymphatic clearance mechanisms. Simultaneously, microglia abandon their protective degradative macroautophagy in favor of hyperactive secretory autophagy, unleashing devastating storms of IL-1β and Cathepsin D via the FKBP5/SKA2 scaffolding complexes. The primary theoretical contribution of this thesis to the field lies in its comprehensive integration of these disparate cellular failures into a unified, glia-centric model of neurodegeneration. By mapping the exact molecular mechanisms—from the retrograde transport blockades at the synapse, to the lysosomal acidification failures mediated by PS1, to the ultimate uncoupling of the neurovascular unit via pericyte senescence—this research provides a highly robust framework for future therapeutic intervention. Moving forward, the targeted pharmacological modulation of autophagic flux represents the most promising frontier for halting the progression of currently incurable neurodegenerative diseases. Specifically, future research must prioritize the development of highly specific, glia-targeted autophagic inducers capable of penetrating the blood-brain barrier. Interventions that can precisely manipulate the mTORC1/TFEB axis to restart stalled flux, restore critical lysosomal pH, and selectively inhibit pathological secretory autophagy pathways in microglia are absolutely paramount to restoring network proteostasis before irreversible synaptic and axonal collapse occurs.

Works cited

1. Hayashide LS, Pessoa B, Dias G, Pontes B, Pinto RS, Diniz LP. From Neuron-Centric to Glia-Centric: How Aging Glial Networks Drive Neurodegenerative Disease. J Neurochem 2026;170(1):e70361. DOI 10.1111/jnc.70361.

2. Kumari N, Anand S. Glia-driven neuroinflammation: Reshaping the neuron-centric model of neurodegenerative disorders. Advanced Neurology 2026;0(0):025520131. DOI 10.36922/an025520131.

3. Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration, accessed February 19, 2026, https://www.frontiersin.org/journals/cellular-neuroscience/articles/ 019.00063/full

4. Hayashide LS, Pessoa B, Dias G, Pontes B, Pinto RS, Diniz LP. From Neuron-Centric to Glia-Centric: How Aging Glial Networks Drive Neurodegenerative Disease. J Neurochem 2026;170(1):e70361. DOI 10.1111/jnc.70361.

5. Nah J, Yuan J, Jung YK. Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells 2015;38(5):381-9. DOI 10.14348/molcells.2015.0034.

6. Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol 2024;25(11):926-946. DOI 10.1038/s41580-024-00757-5.

7. Belgrad J, De Pace R, Fields RD. Autophagy in Myelinating Glia. J Neurosci 2020;40(2):256-266. DOI 10.1523/JNEUROSCI.1066-19.2019.

8. Plaza-Zabala A, Sierra-Torre V, Sierra A. Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging. Int J Mol Sci 2017;18(3). DOI 10.3390/ijms18030598.

9. Kanno H, Handa K, Murakami T, Aizawa T, Ozawa H. Chaperone-Mediated Autophagy in Neurodegenerative Diseases and Acute Neurological Insults in the Central Nervous System. Cells 2022;11(7). DOI 10.3390/cells11071205.

10. Ktena N, Kaplanis SI, Kolotuev I, Georgilis A, Stavroulaki V, Kallergi E, et al.. Autophagy degrades myelin proteins and is essential for maintaining CNS myelin homeostasis. 2022. DOI 10.1101/2022.06.20.496817.

11. Tepavčević V. Oligodendroglial Energy Metabolism and (re)Myelination. Life (Basel) 2021;11(3). DOI 10.3390/life11030238.

12. Volpi VG, Touvier T, D'Antonio M. Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders. Front Mol Neurosci 2016;9:162.ol.2016.00162.

    Find this paper

13. Chaperone-mediated autophagy as a modulator of aging and longevity - Frontiers, accessed February 19, 2026, DOI 10.3389/fragi.2024.1509400">https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2024.1509400

14. Bejarano E, Cuervo AM. Chaperone-mediated autophagy. Proc Am Thorac Soc 2010;7(1):29-39. DOI 10.1513/pats.200909-102JS.

15. Yao R, Shen J. Chaperone-mediated autophagy: Molecular mechanisms, biological functions, and diseases. MedComm (2020) 2023;4(5):e347. DOI 10.1002/mco2.347.

16. Hein ZM, Vishnumukkala T, Karikalan B, Alkatiri A, Hussan F, Jagadeesan S, et al.. Autophagy and Alzheimer's Disease: Mechanisms and Impact Beyond the Brain. Cells 2025;14(12). DOI 10.3390/cells14120911.

17. Wu H, Chen S, Ammar AB, Xu J, Wu Q, Pan K, et al.. Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases. Mol Neurobiol 2015;52(3):1284-1296. DOI 10.1007/s12035-014-8933-0.

18. Schiffmann R, Boespflüg-Tanguy O. An update on the leukodsytrophies. Curr Opin Neurol 2001;14(6):789-94. DOI 10.1097/00019052-200112000-00018.

19. Kokaly N, Guerreiro H, Bredow J, Dreha-Kulaczewski S, Ohlenbusch A, Köhler W, et al.. Description of the Hamburg Alexander Leukodystrophy Cohort-Insights into Practical Classification and the Care Situation. J Clin Med 2025;14(19). DOI 10.3390/jcm14196918.

20. Nutma E, Marzin MC, Cillessen SA, Amor S. Autophagy in white matter disorders of the CNS: mechanisms and therapeutic opportunities. J Pathol 2021;253(2):133-147. DOI 10.1002/path.5576.

21. van der Knaap MS, Bugiani M. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol 2017;134(3):351-382. DOI 10.1007/s00401-017-1739-1.

22. Sawaishi Y. Review of Alexander disease: beyond the classical concept of leukodystrophy. Brain Dev 2009;31(7):493-8. DOI 10.1016/j.braindev.2009.03.006.

23. Moulis M, Vindis C. Methods for Measuring Autophagy in Mice. Cells 2017;6(2):14. DOI 10.3390/cells6020014.

24. Loos B, du Toit A, Hofmeyr JH. Defining and measuring autophagosome flux—concept and reality. Autophagy 2014;10(11):2087-96. DOI 10.4161/15548627.2014.973338.

25. Pei C, Li B, Wen S, Zhao K, Yu S, Li T, et al.. Neuron-specific deficiency of autophagy increases neuronal loss in traumatic brain injury. PNAS Nexus 2024;3(10). DOI 10.1093/pnasnexus/pgae457.

https://academic.oup.com/pnasnexus/advance-article/doi/10.1093/pnasnexus/pga e457/7816829

27. Cell-type-specific regulation of neuronal intrinsic excitability by macroautophagy | eLife, accessed February 19, 2026, https://elifesciences.org/articles/50843

28. Measuring Autophagic Flux: A Simple Guide to How and Why - Bitesize Bio, accessed February 19, 2026, https://bitesizebio.com/49071/measuring-autophagic-flux/

29. Matus S, Valenzuela V, Hetz C. A new method to measure autophagy flux in the nervous system. Autophagy 2014;10(4):710-714. DOI 10.4161/auto.28434.

30. Zhou C, Zhong W, Zhou J, Sheng F, Fang Z, Wei Y, et al.. Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells. Autophagy 2012;8(8):1215-26. DOI 10.4161/auto.20284.

31. Schematic diagram of the tandem mRFP-EGFP-LC3 reporter to monitor... - ResearchGate, accessed February 19, 2026, https://www.researchgate.net/figure/Schematic-diagram-of-the-tandem-mRFPEGFP-LC3-reporter-to-monitor-autophagic-flux-a_fig3_328481070

32. Gottlieb RA, Andres AM, Sin J, Taylor DP. Untangling Autophagy Measurements. Circulation Research 2015;116(3):504-514. DOI 10.1161/circresaha.116.303787.

33. Zhang T, Bhambri A, Zhang Y, Barbosa D, Bae HG, Xue J, et al.. Autophagy collaborates with apoptosis pathways to control oligodendrocyte number. Cell Rep 2023;42(8):112943.2023.112943.

    Find this paper

34. Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders, accessed February 19, 2026, https://www.frontiersin.org/journals/neuroscience/articles/ 51/full

35. Ktena N, Kaplanis SI, Kolotuev I, Georgilis A, Kallergi E, Stavroulaki V, et al.. Autophagic degradation of CNS myelin maintains axon integrity. Cell Stress 2022;6(12):93-107. DOI 10.15698/cst2022.12.274.

36. Castillo K, Valenzuela V, Matus S, Nassif M, Oñate M, Fuentealba Y, et al.. Measurement of autophagy flux in the nervous system in vivo. Cell Death Dis 2013;4(11):e917. DOI 10.1038/cddis.2013.421.

37. Fluorescence lifetime-based biosensor for monitoring compartmentalized autophagy dynamics in the intact mammalian brain | bioRxiv, accessed February 19, 2026, https://www.biorxiv.org/content/

38. Sun LO, Mulinyawe SB, Collins HY, Ibrahim A, Li Q, Simon DJ, et al.. Spatiotemporal Control of CNS Myelination by Oligodendrocyte Programmed Cell Death through the TFEB-PUMA Axis. Cell 2018;175(7):1811-1826.e21. DOI 10.1016/j.cell.2018.10.044.

39. Ktena N, Spyridakos D, Georgilis A, Kalafatakis I, Thomoglou E, Kolaxi A, et al.. Disruption of Oligodendroglial Autophagy Leads to Myelin Morphological Deficits, Neuronal Apoptosis, and Cognitive Decline in Aged Mice. Glia 2025;73(7):1383-1397. DOI 10.1002/glia.70012.

40. Volpi VG, Touvier T, D'Antonio M. Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders. Front Mol Neurosci 2016;9:162.ol.2016.00162.

    Find this paper

41. Volpi VG, Touvier T, D'Antonio M. Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders. Front Mol Neurosci 2016;9:162.ol.2016.00162.

    Find this paper

42. Yang M, Luo S, Wang X, Li C, Yang J, Zhu X, et al.. ER-Phagy: A New Regulator of ER Homeostasis. Front Cell Dev Biol 2021;9:684526. DOI 10.3389/fcell.2021.684526.

43. Stone S, Wu S, Nave KA, Lin W. The UPR preserves mature oligodendrocyte viability and function in adults by regulating autophagy of PLP. JCI Insight 2020;5(5). DOI 10.1172/jci.insight.132364.

44. Peroxisomal Dysfunction in Neurological Diseases and Brain Aging - Frontiers, accessed February 19, 2026, https://www.frontiersin.org/journals/cellular-neuroscience/articles/ 020.00044/full

45. Xu W, Yan J, Shao A, Lenahan C, Gao L, Wu H, et al.. Peroxisome and pexophagy in neurological diseases. Fundam Res 2024;4(6):1389-1397. DOI 10.1016/j.fmre.2023.04.016.

46. Uzor NE, McCullough LD, Tsvetkov AS. Peroxisomal Dysfunction in Neurological Diseases and Brain Aging. Front Cell Neurosci 2020;14:44.020.00044.

    Find this paper

47. Philips T, Mironova YA, Jouroukhin Y, Chew J, Vidensky S, Farah MH, et al.. MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degeneration. Cell Rep 2021;34(2):108610.2020.108610.

    Find this paper

48. Jasutkar HG, Yamamoto A. Autophagy at the synapse, an early site of dysfunction in neurodegeneration. Curr Opin Physiol 2023;32. DOI 10.1016/j.cophys.2023.100631.

49. Del Río Hortega's insights into oligodendrocytes: recent advances in subtype characterization and functional roles in axonal support and disease - Frontiers, accessed February 19, 2026, https://www.frontiersin.org/journals/neuroanatomy/articles/ 57214/full

50. Philips T, Mironova YA, Jouroukhin Y, Chew J, Vidensky S, Farah MH, et al.. MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degeneration. Cell Rep 2021;34(2):108610.2020.108610.

    Find this paper

51. Monocarboxylate Transporter 1 May Benefit Cerebral Ischemia via Facilitating Lactate Transport From Glial Cells to Neurons - Frontiers, accessed February 19, 2026, https://www.frontiersin.org/journals/neurology/articles/ full

52. Monocarboxylate transporter 2 is required for the maintenance of myelin and axonal integrity by oligodendrocytes - bioRxiv.org, accessed February 19, 2026, https://www.biorxiv.org/content/

53. Liu Z, Sneve M, Haroldson TA, Smith JP, Drewes LR. Regulation of Monocarboxylic Acid Transporter 1 Trafficking by the Canonical Wnt/β-Catenin Pathway in Rat Brain Endothelial Cells Requires Cross-talk with Notch Signaling. J Biol Chem 2016;291(15):8059-69. DOI 10.1074/jbc.M115.710277.

https://pmc.ncbi.nlm.nih.gov/articles/PMC4825010/

55. Yang Z, Yu Z, Xiao B. Coordinated Regulation of Myelination by Growth Factor and Amino-acid Signaling Pathways. Neurosci Bull 2023;39(3):453-465. DOI 10.1007/s12264-022-00967-x.

56. Martina JA, Chen Y, Gucek M, Puertollano R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 2012;8(6):903-14. DOI 10.4161/auto.19653.

57. Deleyto-Seldas N, Efeyan A. The mTOR-Autophagy Axis and the Control of Metabolism. Front Cell Dev Biol 2021;9:655731. DOI 10.3389/fcell.2021.655731.

58. Morrison BM, Lee Y, Rothstein JD. Oligodendroglia: metabolic supporters of axons. Trends Cell Biol 2013;23(12):644-51. DOI 10.1016/j.tcb.2013.07.007.

59. Philips T, Mironova YA, Jouroukhin Y, Chew J, Vidensky S, Farah MH, et al.. MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degeneration. Cell Rep 2021;34(2):108610.2020.108610.

    Find this paper

60. Wang Y, Song M, Song F. Neuronal autophagy and axon degeneration. Cell Mol Life Sci 2018;75(13):2389-2406. DOI 10.1007/s00018-018-2812-1.

61. Mollá B, Riveiro F, Bolinches-Amorós A, Muñoz-Lasso DC, Palau F, González-Cabo P. Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich's ataxia. Dis Model Mech 2016;9(6):647-57. DOI 10.1242/dmm.024273.

62. Yue Z, Friedman L, Komatsu M, Tanaka K. The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta 2009;1793(9):1496-507. DOI 10.1016/j.bbamcr.2009.01.016.

63. Yang Y, Coleman M, Zhang L, Zheng X, Yue Z. Autophagy in axonal and dendritic degeneration. Trends Neurosci 2013;36(7):418-28.2013.04.001.

    Find this paper

64. Looser ZJ, Faik Z, Ravotto L, Zanker HS, Jung RB, Werner HB, et al.. Oligodendrocyte-axon metabolic coupling is mediated by extracellular K(+) and maintains axonal health. Nat Neurosci 2024;27(3):433-448. DOI 10.1038/s41593-023-01558-3.

65. Potokar M, Jorgačevski J. Targeting autophagy in astrocytes: a potential for neurodegenerative disease intervention. Front Cell Neurosci 2025;19:1584767.025.1584767.

    Find this paper

66. Targeting autophagy in astrocytes: a potential for neurodegenerative disease intervention, accessed February 19, 2026, https://www.frontiersin.org/journals/cellular-neuroscience/articles/ 025.1584767/full

67. Impaired Microglia Autophagy in Neurodegenerative Diseases - Biospective, accessed February 19, 2026, https://biospective.com/resources/microglia-autophagy-neurodegenerative-dise

ases

68. Ou-Yang P, Cai Z, Zhang Z. Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease. Aging and disease 2023:0. DOI 10.14336/AD.2023.0106.

69. Ou-Yang P, Cai ZY, Zhang ZH. Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease. Aging Dis 2023;14(4):1166-1177. DOI 10.14336/AD.2023.0106.

70. Hartmann J, Bajaj T, Otten J, Klengel C, Ebert T, Gellner AK, et al.. SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration. Nat Commun 2024;15(1):2635. DOI 10.1038/s41467-024-46953-x.

71. Li Q, Peng G, Liu H, Wang L, Lu R, Li L. Molecular mechanisms of secretory autophagy and its potential role in diseases. Life Sci 2024;347:122653. DOI 10.1016/j.lfs.2024.122653.

72. Nixon RA, Yang DS. Autophagy failure in Alzheimer's disease--locating the primary defect. Neurobiol Dis 2011;43(1):38-45. DOI 10.1016/j.nbd.2011.01.021.

73. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, et al.. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010;141(7):1146-58. DOI 10.1016/j.cell.2010.05.008.

74. Zhang X, Garbett K, Veeraraghavalu K, Wilburn B, Gilmore R, Mirnics K, et al.. A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J Neurosci 2012;32(25):8633-48. DOI 10.1523/JNEUROSCI.0556-12.2012.

75. Bordi M, Berg MJ, Mohan PS, Peterhoff CM, Alldred MJ, Che S, et al.. Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy 2016;12(12):2467-2483. DOI 10.1080/15548627.2016.1239003.

76. Nixon RA, Yang DS. Autophagy and neuronal cell death in neurological disorders. Cold Spring Harb Perspect Biol 2012;4(10). DOI 10.1101/cshperspect.a008839.

77. Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19 | Brain Communications | Oxford Academic, accessed February 19, 2026, https://academic.oup.com/braincomms/article/6/2/fcae080/7623634

78. Yang Z, Huang C, Wu Y, Chen B, Zhang W, Zhang J. Autophagy Protects the Blood-Brain Barrier Through Regulating the Dynamic of Claudin-5 in Short-Term Starvation. Front Physiol 2019;10:2. DOI 10.3389/fphys.2019.00002.

79. Kim KA, Kim D, Kim JH, Shin YJ, Kim ES, Akram M, et al.. Autophagy-mediated occludin degradation contributes to blood-brain barrier disruption during ischemia in bEnd.3 brain endothelial cells and rat ischemic stroke models. Fluids Barriers CNS 2020;17(1):21. DOI 10.1186/s12987-020-00182-8.

80. Luo N, Zhu W, Li X, Fu M, Zhang Y, Yang F, et al.. Defective autophagy of pericytes enhances radiation-induced senescence promoting radiation brain injury. Neuro Oncol 2024;26(12):2288-2304. DOI 10.1093/neuonc/noae153.

81. Pericytes Across the Lifetime in the Central Nervous System - Frontiers, accessed February 19, 2026, https://www.frontiersin.org/journals/cellular-neuroscience/articles/ 021.627291/full

82. Milani SZ, Rezabakhsh A, Karimipour M, Salimi L, Mardi N, Narmi MT, et al.. Role of autophagy in angiogenic potential of vascular pericytes. Front Cell Dev Biol 2024;12:1347857. DOI 10.3389/fcell.2024.1347857.

83. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen

Kisler K, Nelson AR, Rege SV, Ramanathan A, Wang Y, Ahuja A, et al.. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat Neurosci 2017;20(3):406-416. DOI 10.1038/nn.4489.